Alyssa S Moravec, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Manteno, IL 60950 Phone: 815-468-6581 |
Clay Dargert, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Manteno, IL 60950 Phone: 815-468-6581 |
Kevin Majchrzak Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Veterans Dr, Manteno, IL 60950 Phone: 815-468-6581 |
News Archive
The accuracy of magnetic resonance imaging (MRI) is not sufficient to rule in or rule out a diagnosis of MS with a high degree of certainty, finds a study published online by the British Medical Journal.
Hospice workers would be allowed to destroy patients' unneeded opioids, reducing the risk that families misuse them, according to one little-noticed provision in the bipartisan opioids bill headed to President Donald Trump's desk for his likely signature.
Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.
Pioneering research by a North East of England scientist could lead to a cure for some of the most deadly antibiotic-resistant diseases.
Prostate cancer screening using the prostate-specific antigen test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented today (Monday) by Professor Mathieu Boniol, at the 2013 European Cancer Congress.
› Verified 8 days ago